PMID: 11901212Mar 20, 2002Paper

Induction of biphasic DNA double strand breaks and activation of multiple repair protein complexes by DNA topoisomerase I drug 7-ethyl-10-hydroxy-camptothecin

Molecular Pharmacology
Jiaxi WuYoucef M Rustum

Abstract

Camptothecins demonstrate a broad spectrum of antitumor activity. Although they are known to trap DNA topoisomerase I on DNA, form cleavable complexes, and generate DNA breaks upon collision with DNA or RNA polymerases, the precise mechanisms predictive for antitumor activity remain to be identified. Recent studies using panels of colorectal and breast cancer cell lines indicate that events downstream of cleavable complexes are more relevant. In this study, we chose SN-38, an active metabolite of irinotecan, to characterize DNA double strand breaks and repair mechanisms induced by this type of drugs using a human head and neck squamous cell carcinoma cell line A253. The results showed that 2-h exposure of cells to an IC(50) concentration of SN-38 induces biphasic DNA double-strand break (DSBs): an immediate phase, which was greatly reduced within 8 h, and a lagging phase, culminating 24 h after drug removal. Three DNA double-strand break repair protein complexes were activated: DNA-dependent protein kinase (DNA-PK), NBS1-MRE11-RAD50, and BRCA1. Aphidicolin, a DNA polymerase inhibitor, abolished both phase I DSBs and the activation of repair protein complexes, suggesting that they resulted from the collision between the cleavabl...Continue Reading

References

Jun 1, 1992·International Journal of Radiation Biology·S J Falk, P J Smith
Oct 1, 1990·International Journal of Radiation Biology·M Frankenberg-Schwager, D Frankenberg
Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·C B BennettM A Resnick
Jul 1, 1997·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J A CollinsM C Willingham
Oct 23, 1997·American Journal of Human Genetics·E A Hendrickson
Mar 28, 1998·The Journal of Biological Chemistry·Z M YuanD Kufe
Apr 23, 1999·The Journal of Biological Chemistry·G ChenE Y Lee
Apr 8, 2000·Current Opinion in Genetics & Development·P Karran
Mar 10, 2001·Nature Genetics·K K Khanna, S P Jackson
Mar 21, 2001·Nature Reviews. Genetics·D C van GentR Kanaar
May 17, 2001·Proceedings of the National Academy of Sciences of the United States of America·T T PaullM Gellert
Aug 16, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Yves PommierGary S. Laco
Aug 16, 2001·The Journal of Biological Chemistry·N Chiba, J D Parvin

❮ Previous
Next ❯

Citations

Jan 12, 2011·Investigational New Drugs·David DavidsonLawrence Panasci
Dec 4, 2003·Mutation Research·Yves PommierKurt W Kohn
Jun 27, 2003·DNA Repair·John C ConnellyDavid R F Leach
Aug 20, 2003·Molecular Biology of the Cell·Tone SandalStein O Døskeland
May 12, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B BurtnessA A Forastiere
Sep 30, 2015·Journal of Cellular and Molecular Medicine·Kwanghyun LeeBong-Gun Ju
Dec 21, 2004·International Journal of Cancer. Journal International Du Cancer·Qi ChenAnlong Xu
Aug 2, 2002·Biochemical and Biophysical Research Communications·Ming-biao YinYoucef M Rustum
Aug 23, 2005·Cancer Chemotherapy and Biological Response Modifiers·Max KreditorHoward S Hochster
Jun 2, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Elena De MattiaGiuseppe Toffoli
Oct 19, 2006·Neuroscience·S F el-Khamisy, K W Caldecott
Mar 25, 2017·The Journal of Eukaryotic Microbiology·Jürgen VoigtJohannes Wöstemeyer
Jul 28, 2006·Organic Letters·Mark A ElbanSidney M Hecht
Apr 17, 2003·British Journal of Cancer·G P FeeneyP J Smith
Apr 3, 2013·International Journal of Oncology·Amélie PetitprezAnnette K Larsen
Jun 16, 2006·Mutagenesis·Sherif F El-Khamisy, Keith W Caldecott

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis